Modern low-molecular-weight heparins in the prevention and treatment of venous thromboembolic complications in oncourologic patients
Oncourologic diseases are accompanied by a risk for subsequent venous thromboembolic complications, which are rated the most dangerous in terms of thrombogenic effect. The article presents a review of the clinical studies of efficacy and safety, and the experience in using of modern low-molecular-we...
| Autors principals: | , |
|---|---|
| Format: | Article |
| Idioma: | Russian |
| Publicat: |
Remedium Group LLC
2018-11-01
|
| Col·lecció: | Медицинский совет |
| Matèries: | |
| Accés en línia: | https://www.med-sovet.pro/jour/article/view/2756 |